Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)

Mehmet Artac,Hakan Bozcuk,Aysel Kiyici,Orhan Onder Eren,Melih Cem Boruban,Mustafa Ozdogan

Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)

2013

Mehmet Artac
Hakan Bozcuk
Aysel Kiyici
Orhan Onder Eren
Melih Cem Boruban
Mustafa Ozdogan

Introduction Our objective was to determine whether serum leptin levels and obesity-related factors could affect outcome for metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs).

Keywords:

Waist–hip ratio
Leptin
Aromatase
Hormonal therapy
Diabetes mellitus
Internal medicine
Endocrinology
Metastatic breast cancer
Medicine
Univariate analysis
Surgical oncology
Oncology
Survival rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations